News & Updates

Frequent hot baths tied to better health in patients with T2D

12 Oct 2020 by

Taking regular hot baths may have a positive impact on glycaemia, blood pressure (BP), and body weight among Japanese patients with type 2 diabetes(T2D), according to a real-world study touted as the first to analyse the effect of heat therapy in T2D.

Frequent hot baths tied to better health in patients with T2D

12 Oct 2020

Bleeding, nausea at 6–8 weeks’ gestation predict pregnancy loss

12 Oct 2020

The risk of clinical pregnancy loss is higher among women who experience vaginal bleeding without nausea between 6 and 8 weeks of gestation, a study has found. Prior to 6 weeks’ gestation, bleeding and nausea are not predictive of clinical pregnancy loss.

Bleeding, nausea at 6–8 weeks’ gestation predict pregnancy loss

12 Oct 2020

Vaginal softgel benefits older women with vulvovaginal atrophy

12 Oct 2020 by

Use of the self-administered TX-004HR – an applicator-free, ultra-low-dose, 17β-oestradiol softgel vaginal insert – led to significant improvements in the symptoms of vulvovaginal atrophy (VVA) such as moderate-to-severe dyspareunia and vaginal dryness in postmenopausal women aged >60 years, according to updated results from the phase III REJOICE trial presented at NAMS 2020.

Vaginal softgel benefits older women with vulvovaginal atrophy

12 Oct 2020

Epicutaneous immunotherapy a durable treatment option against peanut allergies

12 Oct 2020

Continued daily treatment with epicutaneous immunotherapy (EPIT) elicits a stable response in children with peanut allergies, a recent study has found.

Epicutaneous immunotherapy a durable treatment option against peanut allergies

12 Oct 2020

Osimertinib reduces CNS recurrence in resected EGFR-mutated NSCLC

12 Oct 2020 by

In patients with stage IB–IIIA EGFR-mutated (EGFRm) non-small-cell lung cancer (NSCLC) who have undergone complete tumour resection, adjuvant osimertinib significantly reduces the risk of recurrence, including in the central nervous system (CNS), results of an exploratory analysis of the phase III ADAURA trial have shown.

Osimertinib reduces CNS recurrence in resected EGFR-mutated NSCLC

12 Oct 2020

Tranexamic acid reduces bleeding during transbronchial lung biopsies

12 Oct 2020

Prophylactic use of the antifibrinolytic agent tranexamic acid results in less bleeding during transbronchial biopsies, allowing more specimens to be obtained with no additional adverse events, a study has found.

Tranexamic acid reduces bleeding during transbronchial lung biopsies

12 Oct 2020

Therapeutic hypothermia beneficial for postcardiac arrest care

12 Oct 2020

Therapeutic hypothermia (TH) improves neurological outcomes for patients who had sustained cardiac arrests, reports a recent meta-analysis.

Therapeutic hypothermia beneficial for postcardiac arrest care

12 Oct 2020

Maternal fexofenadine use not tied to increased risk of adverse foetal outcomes

12 Oct 2020 by

The use of fexofenadine during pregnancy was not associated with an increased risk of adverse foetal outcomes compared with cetirizine use, according to a recent study in Denmark.